TNFRSF11A and acute myeloid leukemia: Analyses of ATP levels revealed that RANK signaling significantly protected the AML cells from drug-induced cell death induced by either chemotherapeutic agent (Figure 3B; doxorubicin, p = 0.007; cytarabine, p = 0.031).